Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Analyzing Engagement Trends in Rhabdomyosarcoma Clinical Trials: A Study of Participation Patterns Among Those Affected by the Disorder

NCT06029465 is registered in ClinicalTrials.gov with Power Life Sciences Inc. as lead sponsor.

NCT NCT06029465
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06029465 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Analyzing Engagement Trends in Rhabdomyosarcoma Clinical Trials: A Study of Participation Patterns Among Those Affected by the Disorder
Lead sponsor
Power Life Sciences Inc.
Phase
Observational
Overall status
Not yet recruiting
Start date
October 31, 2024
Completion date
October 31, 2026
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rhabdomyosarcoma